New directions for chemoprevention research at the National Cancer Institute: report of the Chemoprevention Implementation Group, September 10, 1999
National Cancer Institute, Division of Cancer Prevention, 1999 - Medical - 45 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Challenges for Chemoprevention
Decision Process for Chemoprevention Trials
Other editions - View all
Agent Development Research Alberts agreed Alberts noted ancillary studies animal models areas basic science research basic scientists Bernard Levin biology biomarker research biomarkers breast cancer BSIS cancer centers cancer incidence Cancer Prevention Cancer Prevention Trials Cancer Research carcinogenesis Cell Biology CGAP chemo chemoprevention research chemoprevention studies Chemopreventive Agent Development Clinical Chemoprevention clinical studies clinical trials collaboration Community Oncology coordinating Decision Committee deﬁne Development Research Group Discussion Division of Cancer drug Early Detection efﬁcacy epidemiology evaluation extramural scientists ﬁeld ﬁrst gene genetics Greenwald Greenwald added identiﬁed intervention investigator-initiated Kopelovich Levin Lowy molecular targets National Cancer Institute nutritional science Omenn Oncology and Prevention opportunities Organ System Research participants Pelling postdoctoral potential preclinical prevention science prevention studies priority Program Director project teams Prostate Cancer recommendations research community Review Group RFAs scientiﬁc Sidransky speciﬁc strategies Subcommittee surrogate endpoints System Research Groups tamoxifen translational research workshops